Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD

[1]  A. Lethaby,et al.  Local oestrogen for vaginal atrophy in postmenopausal women. , 2016, The Cochrane database of systematic reviews.

[2]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[3]  Ž. Bumbulienė,et al.  Microbiological findings of vulvovaginitis in prepubertal girls , 2013, Postgraduate Medical Journal.

[4]  R. Birdwell,et al.  Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. Leach,et al.  Black cohosh (Cimicifuga spp.) for menopausal symptoms. , 2012, The Cochrane database of systematic reviews.

[6]  F. Wojnarowska,et al.  Systematic review and meta-analysis of randomized controlled trials on topical interventions for genital lichen sclerosus. , 2012, Journal of the American Academy of Dermatology.

[7]  M. Jarden,et al.  The impact of hematopoietic stem cell transplantation on sexuality: a systematic review of the literature , 2012, Bone Marrow Transplantation.

[8]  Peter J. Schmidt,et al.  The 2022 hormone therapy position statement of The North American Menopause Society , 2022, Menopause.

[9]  S. Otašević,et al.  Microbiological aspects of vulvovaginitis in prepubertal girls , 2012, European Journal of Pediatrics.

[10]  M. Aljurf,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation , 2012, Bone Marrow Transplantation.

[11]  J. Leonardi-Bee,et al.  Interventions for erosive lichen planus affecting mucosal sites. , 2012, The Cochrane database of systematic reviews.

[12]  C. Gracia,et al.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  L. Hofbauer,et al.  Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: Report from the Consensus Conference on Clinical Practice in chronic graft‐versus‐host disease , 2011, Transplant international : official journal of the European Society for Organ Transplantation.

[14]  H. Einsele,et al.  Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD. , 2011, Vaccine.

[15]  W. Rocca,et al.  Oophorectomy, menopause, estrogen treatment, and cognitive aging: Clinical evidence for a window of opportunity , 2011, Brain Research.

[16]  E. Holler,et al.  Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  K. Schenck-Gustafsson,et al.  EMAS position statement: Managing women with premature ovarian failure. , 2010, Maturitas.

[18]  M. Sorror,et al.  Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[19]  J. Jeruss,et al.  Preservation of fertility in patients with cancer. , 2009, The New England journal of medicine.

[20]  N. Fleming,et al.  Pediatric vulvovaginal disorders: a diagnostic approach and review of the literature. , 2009, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[21]  M. Bouxsein,et al.  Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials. , 2009, The Journal of bone and joint surgery. American volume.

[22]  J. Manson,et al.  Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study , 2009, Obstetrics and gynecology.

[23]  A. Barrett,et al.  Can Routine Posttransplant HPV Vaccination Prevent Commonly Occurring Epithelial Cancers after Allogeneic Stem Cell Transplantation? , 2009, Clinical Cancer Research.

[24]  H. Deeg,et al.  Solid cancers after allogeneic hematopoietic cell transplantation. , 2009, Blood.

[25]  J. Snowden,et al.  Ovarian failure following cancer treatment: current management and quality of life. , 2008, Human reproduction.

[26]  A. Barrett,et al.  Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  D. Couriel.  Ancillary and supportive care in chronic graft-versus-host disease. , 2008, Best practice & research. Clinical haematology.

[28]  W. Satmary,et al.  Non-neoplastic epithelial disorders of the vulva. , 2008, American family physician.

[29]  W. Leisenring,et al.  Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party. , 2008, Blood.

[30]  A. Gratwohl,et al.  Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. , 2007, Blood.

[31]  M. Turner,et al.  Vulvovaginal Chronic Graft-Versus-Host Disease With Allogeneic Hematopoietic Stem Cell Transplantation , 2007, Obstetrics and gynecology.

[32]  L. Melton,et al.  Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause , 2007, Neurology.

[33]  C. Nappi,et al.  Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review , 2007, Menopause.

[34]  J. Szer,et al.  Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management , 2006, Bone Marrow Transplantation.

[35]  L. Gerber,et al.  Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[36]  D. Grobbee,et al.  Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis , 2006, Menopause.

[37]  J. Wingard,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[38]  A. Wolk,et al.  Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women , 2006, Proceedings of the Nutrition Society.

[39]  S. Chiodi,et al.  The management of severe vaginal obstruction from genital chronic graft-versus-host disease: diagnosis, surgical technique and follow-up. , 2006, Minerva ginecologica.

[40]  N. Watts,et al.  Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. , 2006, Archives of internal medicine.

[41]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[42]  E. Gehan,et al.  Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  W. Travis,et al.  Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. , 2005, Blood.

[44]  J. Manson,et al.  Risk of Cardiovascular Disease by Hysterectomy Status, With and Without Oophorectomy: The Women’s Health Initiative Observational Study , 2005, Circulation.

[45]  D. Green,et al.  Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  P. Chiusolo,et al.  Hormonal replacement therapy after stem cell transplantation. , 2004, Maturitas.

[47]  A. Maclennan,et al.  Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. , 2004, The Cochrane database of systematic reviews.

[48]  G. Chrousos,et al.  Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[49]  G. Vogelsang,et al.  Chronic graft versus host disease , 2004, British journal of haematology.

[50]  R. Soiffer,et al.  Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[51]  A. LaCroix,et al.  Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. , 2003, JAMA.

[52]  R. Lindsay,et al.  Short-term urogenital effects of raloxifene, tamoxifen, and estrogen. , 2003, American journal of obstetrics and gynecology.

[53]  A. Tichelli,et al.  Nonmalignant late effects after allogeneic stem cell transplantation. , 2003, Blood.

[54]  J. Rock,et al.  Treatment of vaginal agglutination associated with chronic graft-versus-host disease. , 2002, Fertility and sterility.

[55]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[56]  R. Storb,et al.  Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. , 2002, Blood.

[57]  P. Ljungman,et al.  Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective survey , 2001, The Lancet.

[58]  A. Pasquino,et al.  Recommendations for the diagnosis and management of Turner syndrome. , 2001, The Journal of clinical endocrinology and metabolism.

[59]  A. Tichelli,et al.  Malignant Neoplasms in Long-Term Survivors of Bone Marrow Transplantation , 1999, Annals of Internal Medicine.

[60]  Y. Shufaro,et al.  Vaginal outflow tract obstruction by graft-versus-host reaction , 1999, Bone Marrow Transplantation.

[61]  University of ZimbabweJHPIEGO Cervical Cancer Project.  Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting , 1999, The Lancet.

[62]  C. Delord,et al.  Vaginal stenosis following allogeneic bone marrow transplantation for acute myeloid leukaemia , 1999, Bone Marrow Transplantation.

[63]  N. Ramsay,et al.  Patterns of gonadal dysfunction following bone marrow transplantation , 1998, Bone Marrow Transplantation.

[64]  L. Nelson,et al.  Bone Loss in Young Women With Karyotypically Normal Spontaneous Premature Ovarian Failure , 1998, Obstetrics and gynecology.

[65]  C. A. Hart,et al.  Vulvovaginitis: causes and management. , 1992, Archives of disease in childhood.

[66]  K. Sullivan,et al.  Ovarian function following marrow transplantation for aplastic anemia or leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  K. Sullivan,et al.  Gynecologic Manifestations of Chronic Graft-Versus-Host Disease , 1982, Obstetrics and gynecology.

[68]  L. Gray,et al.  Vulvovaginitis in childhood. , 1960, Clinical obstetrics and gynecology.

[69]  T. Frieden.  Advisory Committee on Immunization Practices (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older--United States, 2013. , 2013, MMWR supplements.

[70]  B. Sandmaier,et al.  Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  P. Stratton,et al.  Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management. , 2012, Seminars in hematology.

[72]  P. Itin,et al.  Diagnosis and Treatment of Lichen Sclerosus An Update , 2012 .

[73]  M. Mohty,et al.  Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[74]  R. Arceci,et al.  Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study , 2011 .

[75]  M. Washington,et al.  Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[76]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[77]  D. Bodurka,et al.  Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation. , 2005, Haematologica.

[78]  A. Bacigalupo,et al.  Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation. , 2003, Haematologica.

[79]  J. Ouslander,et al.  Postmenopausal vaginal atrophy and atrophic vaginitis. , 1997, The American journal of the medical sciences.

[80]  T. J. Gargan.  Turner's syndrome. , 1997, The New England journal of medicine.

[81]  R. Nuscher,et al.  Bone marrow transplantation. , 1977, The American journal of nursing.